Rivaroxaban Evaluation in Real Life Settings "RIVER"


Phase N/A Results N/A

Trial Description

To discover outcomes of patients treated with Rivaroxaban with atrial fibrillation with at least one additional investigator-determined risk factor for stroke in real-life practice.


Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Trial Population

Males and females aged 18 years and over


Type Measure Time Frame Safety Issue
Primary To assess the rate of stroke and systemic embolisation in registry participants 2 years No